Payden & Rygel’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,600
| Closed | -$574K | – | 127 |
|
|
2024
Q3 | $574K | Sell |
2,600
-29,700
| -92% | -$6.56M | 0.04% | 94 |
|
|
2024
Q2 | $6.35M | Buy |
32,300
+29,700
| +1,142% | +$5.84M | 0.51% | 68 |
|
|
2024
Q1 | $560K | Hold |
2,600
| – | – | 0.03% | 101 |
|
|
2023
Q4 | $548K | Hold |
2,600
| – | – | 0.04% | 107 |
|
|
2023
Q3 | $521K | Sell |
2,600
-73,000
| -97% | -$14.6M | 0.04% | 110 |
|
|
2023
Q2 | $14M | Buy |
+75,600
| New | +$14M | 0.99% | 46 |
|
|
2017
Q3 | – | Sell |
-144,000
| Closed | -$18M | – | 120 |
|
|
2017
Q2 | $18M | Hold |
144,000
| – | – | 1.58% | 20 |
|
|
2017
Q1 | $17.1M | Hold |
144,000
| – | – | 1.56% | 23 |
|
|
2016
Q4 | $16.6M | Hold |
144,000
| – | – | 1.53% | 26 |
|
|
2016
Q3 | $15.1M | Buy |
144,000
+12,800
| +10% | +$1.34M | 1.51% | 31 |
|
|
2016
Q2 | $12.8M | Hold |
131,200
| – | – | 1.45% | 33 |
|
|
2016
Q1 | $12.6M | Buy |
131,200
+1,700
| +1% | +$163K | 1.53% | 31 |
|
|
2015
Q4 | $11.7M | Hold |
129,500
| – | – | 1.55% | 27 |
|
|
2015
Q3 | $12M | Hold |
129,500
| – | – | 1.73% | 25 |
|
|
2015
Q2 | $12.1M | Hold |
129,500
| – | – | 1.59% | 25 |
|
|
2015
Q1 | $12.3M | Buy |
129,500
+25,100
| +24% | +$2.38M | 1.6% | 25 |
|
|
2014
Q4 | $9.26M | Buy |
+104,400
| New | +$9.26M | 1.77% | 21 |
|
|
2014
Q2 | – | Sell |
-28,700
| Closed | -$2.12M | – | 220 |
|
|
2014
Q1 | $2.12M | Hold |
28,700
| – | – | 0.83% | 56 |
|
|
2013
Q4 | $2.25M | Buy |
+28,700
| New | +$2.25M | 0.77% | 52 |
|